-
Mashup Score: 1Loader - 21 hour(s) ago
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Advances in Sickle Cell Disease - 2 day(s) ago
Dr. Smith-Whitley, pediatric hematologist at the Children’s Hospital of Philadelphia, discusses the advances in sickle cell disease.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2
For hematologic malignancy (HM) patients admitted to the ICU, survival is 49 percent at seven days and 21 percent at 12 months.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Loader - 5 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Treatment With NALL Beneficial for Niemann-Pick Disease - 7 day(s) ago
Treatment with NALL for 12 weeks yields better neurological status than placebo among patients with Niemann-Pick disease type C.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Rare Disease Impact on Understanding Common Diseases - 7 day(s) ago
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1Personalizing Pharmaceutical Care Through AI - 7 day(s) ago
Bill Grambley explains how his company attacks health inequalities by providing personalized pharmaceutical care with an AI based platform.
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Loader - 7 day(s) ago
We have noticed an unusual activity from your IP 192.133.77.15 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Loader - 7 day(s) ago
We have noticed an unusual activity from your IP 199.16.157.181 and blocked access to this
Source: CheckRare.comCategories: General Medicine News, Rare DiseaseTweet
Petra Oliva, PhD, Archimed Life Science, discusses newborn screening for metachromatic leukodystrophy #MLD #CheckRare #RareDisease https://t.co/BXAZ0bjZOd